Abstract

BackgroundMinimizing adverse reactions caused by drug-drug interactions (DDIs) has always been a prominent research topic in clinical pharmacology. Detecting all possible interactions through clinical studies before a drug is released to the market is a demanding task. The power of big data is opening up new approaches to discovering various DDIs. However, these data contain a huge amount of noise and provide knowledge bases that are far from being complete or used with reliability. Most existing studies focus on predicting binary DDIs between drug pairs and ignore other interactions.ObjectiveLeveraging both drug knowledge graphs and biomedical text is a promising pathway for rich and comprehensive DDI prediction, but it is not without issues. Our proposed model seeks to address the following challenges: data noise and incompleteness, data sparsity, and computational complexity.MethodsWe propose a novel framework, Predicting Rich DDI, to predict DDIs. The framework uses graph embedding to overcome data incompleteness and sparsity issues to make multiple DDI label predictions. First, a large-scale drug knowledge graph is generated from different sources. The knowledge graph is then embedded with comprehensive biomedical text into a common low-dimensional space. Finally, the learned embeddings are used to efficiently compute rich DDI information through a link prediction process.ResultsTo validate the effectiveness of the proposed framework, extensive experiments were conducted on real-world data sets. The results demonstrate that our model outperforms several state-of-the-art baseline methods in terms of capability and accuracy.ConclusionsWe propose a novel framework, Predicting Rich DDI, to predict DDIs. Using rich DDI information, it can competently predict multiple labels for a pair of drugs across numerous domains, ranging from pharmacological mechanisms to side effects. To the best of our knowledge, this framework is the first to provide a joint translation-based embedding model that learns DDIs by integrating drug knowledge graphs and biomedical text simultaneously in a common low-dimensional space. The model also predicts DDIs using multiple labels rather than single or binary labels. Extensive experiments were conducted on real-world data sets to demonstrate the effectiveness and efficiency of the model. The results show our proposed framework outperforms several state-of-the-art baselines.

Highlights

  • An increasing amount of research in clinical studies is focusing on drug-drug interactions (DDIs) because the majority of adverse drug reactions (ADRs) occur between pairs of drugs

  • We propose a novel framework, Predicting Rich DDI, to predict DDIs

  • We investigated Predicting Rich DDI (PRD)’s strengths in modeling rich DDI relations between drug entities

Read more

Summary

Introduction

An increasing amount of research in clinical studies is focusing on drug-drug interactions (DDIs) because the majority of adverse drug reactions (ADRs) occur between pairs of drugs. Detecting DDIs based on experimentation is a time-consuming and laborious process for clinicians This signals the need for a more comprehensive and automated method of predicting unknown DDIs before a new drug can be released. The superior performance of these proposed methods can be attributed to their use of the prior knowledge and learning of higher-level representations for DDI detection. As these approaches only predict binary DDIs or those that have been predefined in structured databases, they may be hampered by robustness caused by data sparsity and vast computation requirements. Most existing studies focus on predicting binary DDIs between drug pairs and ignore other interactions

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call